Integra Lifesciences (IART) 76.75 $IART Integra

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 12:03 PM

Integra Lifesciences (IART) 76.75 $IART

Integra LifeSciences Has Returned 30.3% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Mon Jun 20, 1:06PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 30.30% as of today's recent price of $76.69.
IART: 76.75 (+1.43)

29.5% Return Seen to Date on SmarTrend Integra LifeSciences Call (IART)
Comtex SmarTrend(R) - Fri Jun 10, 1:07PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 4 months, Integra LifeSciences has returned 29.50% as of today's recent price of $76.22.
IART: 76.75 (+1.43)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 76.75 (+1.43), ANIP: 56.16 (+3.37), NEO: 8.27 (-0.13), RTRX: 18.62 (+0.14)

Integra LifeSciences Has Returned 23.6% Since SmarTrend Recommendation (IART)
Comtex SmarTrend(R) - Thu May 26, 1:24PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 23.61% as of today's recent price of $72.75.
IART: 76.75 (+1.43)

Integra LifeSciences to Present at the Jefferies 2016 Healthcare Conference in June 2016
GlobeNewswire - Wed May 25, 3:05PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in June:
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 76.75 (+1.43), HSKA: 34.04 (+0.14), ANIP: 56.16 (+3.37), NEO: 8.27 (-0.13)

Integra LifeSciences launches Integra(R) Fin-Lock(TM) Glenoid for the Titan(TM) Modular Shoulder System
GlobeNewswire - Mon May 23, 7:30AM CDT
Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra(R) Fin-Lock(TM) Glenoid. This addition to the Titan(TM) Modular Shoulder System increases the glenoid offerings to include features intended to help maximize long-term fixation and implant longevity.
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Shares of IART Up 22.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 19, 1:05AM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 22.10% as of today's recent price of $71.86.
IART: 76.75 (+1.43)

Uptrend Call Working As Integra LifeSciences Stock Rises 24.3% (IART)
Comtex SmarTrend(R) - Wed May 11, 1:17PM CDT
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on February 22nd, 2016 at $58.86. In approximately 3 months, Integra LifeSciences has returned 24.27% as of today's recent price of $73.14.
IART: 76.75 (+1.43)

Integra LifeSciences Receives FDA Approval for Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, Clearing the Way for Commercial Release
GlobeNewswire - Wed May 11, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for the packaging of its new product, Integra(R) Omnigraft(TM) Dermal Regeneration Matrix, which clears the way for its commercial release. The product's unique packaging is designed for ease of handling and application in the outpatient wound care setting.
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra LifeSciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference and the UBS Global Healthcare Conference in May 2016
GlobeNewswire - Tue May 03, 3:15PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in May:
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra (IART) Beats on Q1 Earnings, Grows Organically
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 12:36PM CDT
Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share (EPS) of 74 cents in the first quarter of 2016.
IART: 76.75 (+1.43), ANIP: 56.16 (+3.37), ANIK: 51.07 (+0.80), ALQA: 1.17 (+0.02)

Integra LifeSciences Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 5:01AM CDT
Revenue of $236.8 million; Organic Revenue Increased 8.9%;
IART: 76.75 (+1.43)

Integra LifeSciences Provides Update for Omnigraft(TM) Commercialization Plans, Including Expectations for an Earlier Launch
GlobeNewswire - Wed Apr 27, 5:00AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is prepared to launch Omnigraft(TM) Dermal Regeneration Matrix in June 2016, pending receipt of final U.S. Food and Drug Administration (FDA) packaging approval.
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra LifeSciences Announces Agreement with AlloSource(R) to Commercialize HuMend(TM), Human Acellular Dermal Matrix
GlobeNewswire - Tue Apr 26, 3:15PM CDT
Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced its entry into an agreement with AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing.
IART: 76.75 (+1.43)

Integra LifeSciences Announces Initial Clinical Use of the Cadence(TM) Total Ankle System in the United States
GlobeNewswire - Tue Apr 26, 3:15PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first ten procedures using the Integra(R) Cadence Total Ankle System were successfully completed by Dr. Selene Parekh and Dr. David Pedowitz.
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra LifeSciences Announces Agreement with Vomaris Wound Care, Inc. to Commercialize VolTAC(TM) Antimicrobial Wound Dressing
GlobeNewswire - Thu Apr 14, 7:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its subsidiary, Integra LifeSciences Corporation, has entered into an agreement with Vomaris Wound Care, Inc., a company specializing in microcurrent solutions for the advanced wound care market. Vomaris's Advanced Microcurrent Technology(R) (AMT) platform recently earned Frost & Sullivan's 2016 Best Practices Award for New Product Innovation for pioneering technology that utilizes electrical energy for wound management.
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra LifeSciences to Host Its First Quarter 2016 Earnings Results Conference Call on April 27, 2016
GlobeNewswire - Wed Apr 06, 3:00PM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its first quarter 2016 financial results on Wednesday, April 27, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
IART: 76.75 (+1.43), IARTV: 65.00 (-37.45)

Integra LifeSciences Awarded $10.3 Million Department of Defense Contract
GlobeNewswire - Thu Mar 10, 7:30AM CST
Integra LifeSciences Holding Corporation (NASDAQ:IART), a leading global medical technology company, today announced that through its partnership with Buffalo Supply, it has received a five-year, $10.3 million contract with the U.S. Department of Defense (DoD), to provide greater access to both its Specialty Surgical Solutions and Orthopedics & Tissue Technology products. The contract is specified for the Defense Logistics Agency (DLA) Medical Electronic Catalogue (ECAT). The DLA purchases approximately $4.5 billion of medical material each year for DoD facilities around the world, as well as other U.S. federal agencies.
IART: 76.75 (+1.43)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...